We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Clinical trials often struggle to recruit enough participants, with only 10% of eligible patients enrolling. This is concerning for conditions like stroke, where timely decision-making is crucial. Frontline clinicians typically screen patients manually, but this approach can be overwhelming and lead to many eligible patients being overlooked.
Methods:
To address the problem of efficient and inclusive screening for trials, we developed a matching algorithm using imaging and clinical variables gathered as part of the AcT trial (NCT03889249) to automatically screen patients by matching these variables with the trials’ inclusion and exclusion criteria using rule-based logic. We then used the algorithm to identify patients who could have been enrolled in six trials: EASI-TOC (NCT04261478), CATIS-ICAD (NCT04142125), CONVINCE (NCT02898610), TEMPO-2 (NCT02398656), ESCAPE-MEVO (NCT05151172), and ENDOLOW (NCT04167527). To evaluate our algorithm, we compared our findings to the number of enrollments achieved without using a matching algorithm. The algorithm’s performance was validated by comparing results with ground truth from a manual review of two clinicians. The algorithm’s ability to reduce screening time was assessed by comparing it with the average time used by study clinicians.
Results:
The algorithm identified more potentially eligible study candidates than the number of participants enrolled. It also showed over 90% sensitivity and specificity for all trials, and reducing screening time by over 100-fold.
Conclusions:
Automated matching algorithms can help clinicians quickly identify eligible patients and reduce resources needed for enrolment. Additionally, the algorithm can be modified for use in other trials and diseases.
Benghal dayflower and sicklepod are weeds of economic importance in peanut in the southeastern United States due to their extended emergence pattern and limited effective herbicides for control. Field studies were conducted near Jay, Florida, in 2022 and 2023, to evaluate the effect of planting date and herbicide combinations on Benghal dayflower and sicklepod control in peanut crops. Peanut planted in June was exposed to a higher Benghal dayflower density than peanut planted in May. Sicklepod density was similar between May and June planting dates at 28 d after preemergence and early postemergence herbicide applications, but density was greater in peanut that was planted in June, 28 d after the mid-postemergence application. A preemeergence herbicide application followed by (fb) an early postemergence application of S-metolachlor or diclosulam + S-metolachlor controlled Benghal dayflower 84% to 93% 28 d after early postemergence in peanut that was planted in May, but control was reduced to 58% to 78% in the crop that had been planted in June. Regardless of planting date, a preemeergence application fb S-metolachlor or diclosulam + S-metolachlor applied early postemergence provided <80% sicklepod control 28 d after early postemergence. Imazapic + dimethenamid-P + 2,4-DB applied postemergence improved Benghal dayflower control to at least 94% 28 d after mid-postemergence, but sicklepod control was not >85%. Regardless of the planting date, paraquat + bentazon + S-metolachlor applied early postemergence was required to achieve ≥95% sicklepod control. However, herbicide combinations that included paraquat + bentazon + S-metolachlor reduced peanut yield when planting was delayed to June. In fields that are infested with Benghal dayflower and sicklepod, it is recommended that peanut be planted in early May to minimize the potential impact of these weeds and to increase peanut yield. Late-planted peanut required more intensive herbicide applications to obtain the same peanut yield as the May-planted peanut.
Sicklepod is one of the most difficult to control weeds in peanut production in the southeastern United States due to its extended emergence pattern and limited effective herbicides for control. Growers rely on preemergence herbicides as the foundation of their weed control programs; however, postemergence herbicides are often needed for season-long weed control. The objectives of this study were to evaluate the effect of planting pattern and herbicide combinations for sicklepod control in peanut crops. Due to rapid canopy closure, twin-row planting improved late-season sicklepod control by 13% and peanut yield by 5% compared with a single-row pattern. A preemergence application of fluridone, flumioxazin, or fluridone + flumioxazin provided 76% to 89% control of sicklepod 28 d after preemergence. Regardless of the herbicide applied preemergence, paraquat + bentazon + S-metolachlor applied early postemergence was required to achieve ≥90% sicklepod control 28 d after early postemergence. All preemergence herbicide treatments followed by (fb) S-metolachlor or diclosulam + S-metolachlor applied early postemergence provided <90% control 28 d after early postemergence. A mid-postemergence application of imazapic + dimethenamid-P + 2,4-DB controlled sicklepod by 67% to 79% prior to peanut harvest, and biomass reduction was unacceptable (<80%), resulting in difficulty in peanut digging. The highest peanut yield was observed when paraquat + bentazon + S-metolachlor was applied early postemergence fb imazapic + dimethenamid-P + 2,4-DB applied mid-postemergence. Based on the results of this study, a herbicide combination of paraquat + bentazon + S-metolachlor is an important early-season tool for controlling sicklepod in peanut crops. The results also showed that a twin-row planting pattern improved late-season sicklepod control but did not reduce herbicide input to protect peanut yield.
Background: Currently there are no disease modifying treatment for Synucleinopathies including Parkinson’s disease Dementia (PDD). Carrying a mutation in the GBA gene (beta-glucocerebrosidase/ GCAse) is a leading risk factor for synucleinopathies. Raising activity GCAse lowers α-synuclein levels in cells and animal models. Ambroxol is a pharmacological chaperone for GCAse and can raise GCAse levels. Our goal is to test Ambroxol as a disease-modifying treatment in PDD. Methods: We randomized fifty-five individuals with PDD to Ambroxol 1050mg/day, 525mg/day, or placebo for 52 weeks. Primary outcome measures included safety, Alzheimer’s disease Assessment Scale-cognitive (ADAS-Cog) subscale and the Clinician’s Global Impression of Change (CGIC). Secondary outcomes included pharmacokinetics, cognitive and motor outcomes and and plasma and CSF biomarkers. Results: Ambroxol was well tolerated. There were 7 serious adverse events (SAEs) none deemed related to Ambroxol. GCase activity was increased in white blood cells by ~1.5 fold. There were no differences between groups on primary outcome measures. Patients receiving high dose Ambroxol appeared better on the Neuropsychiatric Inventory. GBA carriers appeared to improve on some cognitive tests. pTau 181 was reduced in CSF. Conclusions: Ambroxol was safe and well-tolerated in PDD. Ambroxol may improve biomarkers and cognitive outcomes in GBA1 mutation carrie.rs Ambroxol improved some biomarkerss. ClinicalTrials.gov NCT02914366
In this paper, we construct interpretable zero-inflated neural network models for modeling hospital admission counts related to respiratory diseases among a health-insured population and their dependants in the United States. In particular, we exemplify our approach by considering the zero-inflated Poisson neural network (ZIPNN), and we follow the combined actuarial neural network (CANN) approach for developing zero-inflated combined actuarial neural network (ZIPCANN) models for modeling admission rates, which can accommodate the excess zero nature of admission counts data. Furthermore, we adopt the LocalGLMnet approach (Richman & Wüthrich (2023). Scandinavian Actuarial Journal, 2023(1), 71–95.) for interpreting the ZIPNN model results. This facilitates the analysis of the impact of a number of socio-demographic factors on the admission rates related to respiratory disease while benefiting from an improved predictive performance. The real-life utility of the methodologies developed as part of this work lies in the fact that they facilitate accurate rate setting, in addition to offering the potential to inform health interventions.
Targeted spraying application technologies have the capacity to drastically reduce herbicide inputs, but to be successful, the performance of both machine vision–based weed detection and actuator efficiency needs to be optimized. This study assessed (1) the performance of spotted spurge recognition in ‘Latitude 36’ bermudagrass turf canopy using the You Only Look Once (YOLOv3) real-time multiobject detection algorithm and (2) the impact of various nozzle densities on model efficiency and projected herbicide reduction under simulated conditions. The YOLOv3 model was trained and validated with a data set of 1,191 images. The simulation design consisted of four grid matrix regimes (3 × 3, 6 × 6, 12 × 12, and 24 × 24), which would then correspond to 3, 6, 12, and 24 nonoverlapping nozzles, respectively, covering a 50-cm-wide band. Simulated efficiency testing was conducted using 50 images containing predictions (labels) generated with the trained YOLO model and by applying each of the grid matrixes to individual images. The model resulted in prediction accuracy of an F1 score of 0.62, precision of 0.65, and a recall value of 0.60. Increased nozzle density (from 3 to 12) improved actuator precision and predicted herbicide-use efficiency with a reduction in the false hits ratio from ∼30% to 5%. The area required to ensure herbicide deposition to all spotted spurge detected within images was reduced to 18%, resulting in ∼80% herbicide savings compared to broadcast application. Slightly greater precision was predicted with 24 nozzles but was not statistically different from the 12-nozzle scenario. Using this turf/weed model as a basis, optimal actuator efficacy and herbicide savings would occur by increasing nozzle density from 1 to 12 nozzles within the context of a single band.
Carrier water quality is an important consideration for herbicide efficacy. Field and greenhouse studies were conducted from 2021 to 2023 to evaluate the effect of carrier water pH and hardness on imazapic efficacy for sicklepod control in peanut crops. In separate field experiments imazapic was applied postemergence at 0.071 kg ai ha−1 with carrier water pH levels of 5, 6, 7, 8, or 9; and hardness levels of 0 (deionized water), 100, 200, 400, or 500 mg L−1 of CaCO3 equivalent. In greenhouse experiments, imazapic was applied to sicklepod that was either 10 cm, 15 cm, or 20 cm tall at similar carrier water pH levels and hardness levels of 0, 100, 200, 400, or 800 mg L−1 of CaCO3. In the field study, sicklepod control, density, and biomass reductions were lower with carrier water pH 5 or 9 compared with pH 7. In the greenhouse study, control was not different among carrier water pH levels when imazapic was applied to 10-cm-tall sicklepod; however, when applied to 15- or 20-cm-tall sicklepod, control was at least 25% greater with acidic (pH 5) compared to alkaline (pH 9) carrier water. Results from the field study showed that carrier water hardness ≤500 ppm did not reduce the efficacy of imazapic to control sicklepod. In the greenhouse study, regardless of sicklepod height, carrier water hardness of 800 mg L−1 reduced sicklepod control by 15% and biomass reduction by 17% compared with deionized water (pH 7). The effects of carrier water pH and hardness on imazapic efficacy did not compromise peanut yield in the field study. However, this study indicates that both acidic and alkaline carrier water pH and hardness (800 mg L−1 CaCO3 L−1) have the potential to reduce imazapic efficacy on sicklepod, and appropriate spray solution amendments maybe be needed to maintain optimum efficacy.
Herbicides are the primary tool for controlling weeds in peanut (Arachis hypogaea L.) and are crucial to sustainable peanut production in the United States. The literature on chemical weed management in peanut in the past 53 yr (1970 to 2022) in the United States was systematically reviewed to highlight the strengths and weaknesses of different herbicides and identify current research gaps in chemical weed management. Residual weed control in peanut is achieved mainly with dimethenamid-P, ethalfluralin, pendimethalin, and S-metolachlor. More recently, the use of the protoporphyrinogen oxidase inhibitor flumioxazin and acetolactate synthase inhibitors, such as diclosulam, for residual weed control in peanut has increased considerably. Postemergence broadleaf weed control in peanut is achieved mainly with acifluorfen, bentazon, diclosulam, imazapic, lactofen, paraquat, and 2,4-DB, while the graminicides clethodim and sethoxydim are the major postemergence grass weed control herbicides in peanut. Although several herbicides are available for weed control in peanut, no single herbicide can provide season-long weed control due to limited application timing, lack of extended residual activity, variability in weed control spectrum, and rotational restrictions. Therefore, effective weed management in peanut often requires herbicide mixtures and/or sequential application of preplant-incorporated, preemergence, and/or postemergence herbicides. However, the available literature showed a substantive range in herbicide efficacy due to variations in environmental conditions and flushes of weed germination across years and locations. Despite the relatively high efficacy of herbicides, the selection of herbicide-resistant weeds is another area of increasing concern. Future research should focus on developing new strategies for preventing or delaying the development of resistance and improving herbicide efficacy within the context of climate change and emerging constraints such as water shortages, rising temperatures, and increasing CO2 concentration.
Older adults living in residential care often experience challenges in sustaining meaningful social relationships, which can result in compromised health and well-being. Online social networking has the potential to mitigate this problem, but few studies have investigated its implementation and its effectiveness in maintaining or enhancing well-being. This pilot study used a cluster-randomized pre–post design to examine the feasibility of implementing a 12-week group-based technology-training intervention for older adults (n = 48) living in residential care by exploring how cognitive health, mental health, and confidence in technology were impacted. Analysis of variance revealed significant increases in life satisfaction, positive attitudes toward computer use, and self-perceived competence among participants who received the intervention, but increased depressive symptoms for the control group. These findings suggest that, despite challenges in implementing the intervention in residential care, group-based technology training may enhance confidence among older adults while maintaining or enhancing mental health.
Insomnia in depression is common and difficult to resolve. Music is commonly used as a sleep aid, and clinical trials pointing to positive effects of music as a sleep aid are increasing adding to the evidence base. There is little knowledge on the effectiveness of music for depression related insomnia.
Objectives
A recent RCT study conducted in psychiatry at Aalborg University Hospital examined effects of a music intervention for insomnia in depression. The intervention group listened to music at bedtime for four weeks, controls were offered music intervention post-test. Primary outcome measure was Pittsburgh Sleep Quality Index (PSQI). Secondary outcomes included Actigraphy, The Hamilton depression Rating Scale (HAMD-17) and World Health Organisation well-being questionnaires (WHO-5, WHOQOL-BREF).
Methods
A two-armed randomized controlled trial (n=112) and a qualitative interview study (n=4)
Results
The RCT study showed signficant improvements for the music intervention group in sleep quality and quality of life at four weeks according to global PSQI scores (effect size= -2.1, 95%CI -3.3; -0.9) and WHO-5 scores (effect size 8.4, 95%CI 2.7; 14.0). Actigraphy measures showed no changes and changes in depression symptoms (HAMD-17) were not detected.
The interview study unfolded examples of the influences of music on sleep and relaxation. Music distracted, affected mood and arousal positively and supported formation of sleep habits.
Results from the trial are discussed and merged with findings from the interview study. The results from the trial suggested moderate effects of music listening for the population while findings from the interview study showed examples of individual and highly varying outcomes.
Conclusions
Music is suggested as a low-cost, side-effect free and safe intervention in supplement to existing treatments improving sleep in depression.
Weed interference is a major factor that reduces peanut (Arachis hypogaea L.) yield in the United States. Peanut growers rely heavily on herbicides for weed control. Although effective, herbicides are not a complete solution to the complex challenge that weeds present. Therefore, the use of nonchemical weed management options is essential. The literature on weed research in peanut in the past 53 yr in the United States was reviewed to assess the achievements and identify current research gaps and prospects for nonchemical weed management for future research. More than half (79%) of the published studies were from the southeastern United States. Most studies (88%) focused on weed management, while fewer studies (12%) addressed weed distribution, ecology, and competitive mechanisms. Broadleaf weeds were the most frequently studied weed species (60%), whereas only 23% and 19% of the published studies were relevant to grasses and Cyperus spp., respectively. Seventy-two percent of the published studies focused on curative measures using herbicides. Nonchemical methods using mechanical (5%) and preventive (13%) measures that influence crop competition and reduce the buildup of the weed seedbank, seedling recruitment, and weed seed production have received less attention. In most studies, the preventive weed management measures provided weed suppression and reduced weed competition but were not effective enough to reduce the need for herbicides to protect peanut yield. Therefore, future research should focus on developing integrated weed management strategies based on multiple preventive measures rather than one preventive measure combined with one or more curative measures. We recommend that research on mechanical weed management should focus on the role of cultivation when integrated with currently available herbicides. For successful weed management with lasting outcomes, the dominant weed communities of specific target locations should be addressed within the context of climate change and emerging constraints rather than focusing on single problematic species.
Over the past fifteen years, a narrative has developed that IR scholars have become a “cult of the irrelevant,” with declining influence on and engagement with policy debates. Despite these assertions, the evidence for limited policy engagement has been anecdotal. We investigate the extent of policy engagement—the ways in which IR scholars participate in policy-making processes and/or attempt to shape those processes—by surveying IR scholars directly about their engagement activities. We find policy engagement is pervasive among IR scholars. We draw on theories of credit-claiming to motivate expectations about how and when scholars are likely to engage with practitioners. Consistent with our expectations, much of this engagement comes in forms that involve small time commitments and provide opportunities for credit-claiming, such as media appearances and short-form, bylined op-eds and blog posts. However, sizable minorities report engaging in consulting activities not for attribution/publication and writing policy briefs, and a majority of respondents indicate they engaged in these activities several times a year or more. We find only small differences in engagement across gender and rank. Our results demonstrate that, for IR scholars, some form of policy engagement is the norm.
To evaluate the impact of implementing clinical decision support (CDS) tools for outpatient antibiotic prescribing in the emergency department (ED) and clinic settings.
Design:
We performed a before-and-after, quasi-experimental study that employed an interrupted time-series analysis.
Setting:
The study institution was a quaternary, academic referral center in Northern California.
Participants:
We included prescriptions for patients in the ED and 21 primary-care clinics within the same health system.
Intervention:
We implemented a CDS tool for azithromycin on March 1, 2020, and a CDS tool for fluoroquinolones (FQs; ie, ciprofloxacin, levofloxacin, and moxifloxacin) on November 1, 2020. The CDS added friction to inappropriate ordering workflows while adding health information technology (HIT) features to easily perform recommended actions. The primary outcome was the number of monthly prescriptions for each antibiotic type, by implementation period (before vs after).
Results:
Immediately after azithromycin-CDS implementation, monthly rates of azithromycin prescribing decreased significantly in both the ED (−24%; 95% CI, −37% to −10%; P < .001) and outpatient clinics (−47%; 95% CI, −56% to −37%; P < .001). In the first month after FQ-CDS implementation in the clinics, there was no significant drop in ciprofloxacin prescriptions; however, there was a significant decrease in ciprofloxacin prescriptions over time (−5% per month; 95% CI, −6% to −3%; P < .001), suggesting a delayed effect of the CDS.
Conclusion:
Implementing CDS tools was associated with an immediate decrease in azithromycin prescriptions, in both the ED and clinics. CDS may serve as a valuable adjunct to existing antimicrobial stewardship programs.
Public health authorities recommend symptom monitoring of healthcare personnel (HCP) after defined exposures to monkeypox. We report on the rapid development and implementation of mobile responsive survey solutions for notification of possible exposure, exposure risk assessment and stratification, and symptom monitoring.
Setting:
An academic health center in Boston, Massachusetts, after admission of first diagnosed case of monkeypox in the United States during the current global outbreak.
Participants:
Research Electronic Data Capture (REDCap) design and programmers, infection control, occupational health, and emergency preparedness specialists, and HCP with possible exposure to monkeypox.
Interventions:
Design and deployment of REDCap tools to identify HCP with possible exposure to monkeypox, to perform exposure risk assessment and stratification for postexposure prophylaxis (PEP), and to conduct symptom monitoring during the exposure window. Project enhancements included dashboards for HCP tracking and short message service (SMS text) reminders for symptom monitoring.
Results:
Tools to support the contact tracing and exposure investigation were deployed within 24 hours of identification of a patient with suspected monkeypox, with the full suite in production within 4 days of confirmation of the monkeypox diagnosis. Clinical follow-up of HCP was integrated into the design, and real-time versioning allowed for improvements in HCP symptom monitoring compliance and enhanced tracking.
Conclusions:
During the current monkeypox outbreak, timely and comprehensive evaluation of potential HCP exposures is necessary but presents logistical challenges. Rapid development of monkeypox-specific solutions using REDCap facilitated flexibility in design and approach, and integration of targeted clinical support enhanced functionality.
Asymptomatic bacteriuria (ASB) is common among hospitalized patients and often leads to inappropriate antimicrobial use. Data from critical-access hospitals are underrepresented. To target antimicrobial stewardship efforts, we measured the point prevalence of ASB and detected a high frequency of ASB overtreatment across academic, community, and critical-access hospitals.
Anti-selection occurs when information asymmetry exists between insurers and applicants. When an applicant knows they are at high risk of loss, but the insurer does not, the applicant may try to use this knowledge differential to secure insurance at a lower premium that does not match risk.
Ginsenosides, biologically active components of the root of Panax ginseng, have been reported to have therapeutic benefits in a number of disease states including psychiatric conditions such as major depressive disorder. Our objective was to determine if a standardised commercial ginseng extract, G115®, could reduce the signs of behavioural despair commonly observed in animal models of depression either alone or in combination with the selective serotonin reuptake inhibitor (SSRI) fluoxetine.
Methods:
Male Sprague-Dawley (SD) rats (N = 51) were divided into four groups: vehicle control, G115® ginseng root extract, fluoxetine and fluoxetine plus G115®. Rats were trained to voluntarily consume treatments twice daily for 14 days and were then tested in an open field (OF), elevated plus maze (EPM) and forced swim test (FST). Post-mortem hippocampal and prefrontal cortex tissue was analysed for expression of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) by western blot.
Results:
One-way Analysis of Variance revealed no significant group differences in the OF or plus-maze performance on any variable examined. In the FST, fluoxetine significantly reduced immobility time and increased latency to immobility. The effects of fluoxetine were further significantly potentiated by co-administration of G115®. Post-mortem tissue analysis revealed significant group differences in BDNF expression in the left hippocampus and left prefrontal cortex without any accompanying changes in TrkB expression.
Conclusions:
We conclude that oral G115® significantly potentiates the antidepressant-like effect of fluoxetine in the FST in the absence of potentially confounding effects on locomotion and anxiety.
Schizophrenia is a disorder characterized by pervasive deficits in cognitive functioning. However, few well-powered studies have examined the degree to which cognitive performance is impaired even among individuals with schizophrenia not currently on antipsychotic medications using a wide range of cognitive and reinforcement learning measures derived from cognitive neuroscience. Such research is particularly needed in the domain of reinforcement learning, given the central role of dopamine in reinforcement learning, and the potential impact of antipsychotic medications on dopamine function.
Methods
The present study sought to fill this gap by examining healthy controls (N = 75), unmedicated (N = 48) and medicated (N = 148) individuals with schizophrenia. Participants were recruited across five sites as part of the CNTRaCS Consortium to complete tasks assessing processing speed, cognitive control, working memory, verbal learning, relational encoding and retrieval, visual integration and reinforcement learning.
Results
Individuals with schizophrenia who were not taking antipsychotic medications, as well as those taking antipsychotic medications, showed pervasive deficits across cognitive domains including reinforcement learning, processing speed, cognitive control, working memory, verbal learning and relational encoding and retrieval. Further, we found that chlorpromazine equivalency rates were significantly related to processing speed and working memory, while there were no significant relationships between anticholinergic load and performance on other tasks.
Conclusions
These findings add to a body of literature suggesting that cognitive deficits are an enduring aspect of schizophrenia, present in those off antipsychotic medications as well as those taking antipsychotic medications.